Proton range verification with PET: 68Zn, Cu and polycarbonate activation SNMMI Young Investigator Symposium, Vancouver, June 9, 2013 Cho J1, Ibbott.

Slides:



Advertisements
Similar presentations
Harvard Medical School Massachusetts General Hospital.
Advertisements

Results/Discussion cont’d. Excluding data past the depth of 10% dose, 91% of points passed. A trend towards over-response was noted in the BANG3-Pro2 dosimeter.
Implementing Technology to Improve Medication Safety and Efficiency in the Pharmacy Kelley Reece, Pharm.D. Assistant Manager MD Anderson Cancer Center.
Orthogonal and Least-Squares Based Coordinate Transforms for Optical Alignment Verification in Radiosurgery Ernesto Gomez PhD, Yasha Karant PhD, Veysi.
Ionization Chamber Array for External Beam Radiotherapy
Experience, Expertise and a Commitment to Excellence™
Alexander Klyachko, IU Cyclotron, PTCOG51, Seoul, South Korea, May 17-19, 2012 A.V. Klyachko 1, D.F. Nichiporov 1, L. Coutinho 2, C.-W. Cheng 2, 3, M.
Algorithms used in heterogeneous dose calculations show systematic error as measured with the Radiological Physics Center’s anthropomorphic thorax phantom.
University of Florida, Jacksonville, FL
Stereotactic Radiosurgery Jimmy Johannes Physics 335 – Spring 2004 Final Presentation
Interactions of charged particles with the patient I.The depth-dose distribution - How the Bragg Peak comes about - (Thomas Bortfeld) II.The lateral dose.
Design and Scheduling of Proton Therapy Treatment Centers Stuart Price, University of Maryland Bruce Golden, University of Maryland Edward Wasil, American.
Simulating Potential Layouts for a Proton Therapy Treatment Center Stuart Price-University of Maryland Bruce Golden- University of Maryland Edward Wasil-
Prediction of Regional Tumor Spread Using Markov Models Megan S. Blackburn Monday, April 14, 2008.
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.
Proton Therapy for Chondrosarcomas of the Skull Base and Cervical Spine: Long-term Experience at Loma Linda University Medical Center D. Y. Kim 2, R. W.
Kerrington Smith, M.D. CTOS Nov 14, 2008
Evaluation of the Performance of the Fast Scanning Platform of an OCT System Malcolm Heard 1, Miguel Herrera 1, Geoffrey Ibbott 1 1 Department of Radiation.
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
Bragg Peak By: Megan Whitley. Bragg Peak  Bragg Peak is the characteristic exhibited by protons that makes them SO appealing for cancer treatment. 
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/2/09.
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 9/30/10.
ASNR 2012 Methodology for Imaging Genomics of Gliomas
Clinical variables, pathological factors, and molecular markers for enhanced soft tissue sarcoma prognostication G. Lahat, B. Wang, D. Tuvin, DA. Anaya,
1 A Comprehensive Study on the Heterogeneity Dose Calculation Accuracy in IMRT using an Anthropomorphic Thorax Phantom S Davidson 1, R Popple 2, G Ibbott.
DEPT OF RADIATION ONCOLOGY Clinical Evaluation of a Novel 4D-CBCT Reconstruction Scheme Based on Simultaneous Motion Estimation and Image Reconstruction.
Physics of carbon ions and principles of beam scanning G. Kraft Biophysik, GSI, Darmstadt, Germany PTCOG43 Educational Satellite Meeting: Principles of.
K. Pulliam, MS 1,2., D Followill, PhD 2., L Court, PhD 2., L Dong, PhD 3., M Gillin, PhD 2., K Prado, PhD 3., S Kry, PhD 2 1 The University of Texas Graduate.
Introduction The Radiological Physics Center (RPC) anthropomorphic quality assurance (QA) phantom program is one tool the RPC uses to remotely audit institutions.
ESTRO, Geneva 2003 The importance of nuclear interactions for dose calculations in proton therapy M.Soukup 1, M.Fippel 2, F. Nuesslin 2 1 Department of.
TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.
A Proton Therapy Overview Richard Eckart And David Turberville Richard Eckart And David Turberville.
Purpose N-isopropylacrylamide (NIPAM) polymer gel dosimeters were employed to verify the dose distribution of clinical intensity modulated radiation therapy.
The Optimization of Reconstruction Method Reducing Partial Volume Effect in PET/CT 3D Image Acquisition Department of Nuclear Medicine, Samsung Medical.
A comparison between soft tissue and bone registration techniques for prostate radiotherapy Richard Small, Paul Bartley, Audrey Ogilvie, Nick West and.
Special Seminar Series
5.5 Medical Applications Using Radioactivity
Characterization of proton-activated implantable markers for proton range verification using PET J. Cho1, G. Ibbott1, M. Kerr1, R. A. Amos2, F. Stingo1,
J Cho, G Ibbott, M Kerr, R Amos, and O Mawlawi
Methods & Materials (continued)
J Cho, G Ibbott, M Gillin, C Gonzalez-Lepera, U Titt and O Mawlawi
Brief pain inventory. (Reproduced with permission from the University of Texas MD Anderson Cancer Center, Department of Symptom Research, Houston, TX.
CT Scan vs MRI.
By: Matthew Kosch Advantages and Recent Implementation of Fiducials in Image-Guided Radiation Therapy.
Radiation therapy for Early Stage Prostate Cancer
Proton beam range verification using proton activated fiducials and off-site PET AAPM Best in Physics, Indianapolis, August 7, 2013 Cho J1, Ibbott G1,
Quantitative Nuclear Medicine Imaging
Very High Energy Electron for Radiotherapy Studies
Evaluation Of RTOG Guidelines For Monte Carlo Based Lung SBRT Planning
Development and characterization of the Detectorized Phantom for research in the field of spatial fractionated radiation therapy. D. Ramazanov, V. Pugatch,
Template Matching Can Accurately Track Tumor Evaluation of Dose Calculation of RayStation Planning System in Heterogeneous Media Huijun Xu, Byongyong Yi,
Comparison of carina- versus bony anatomy-based registration for setup verification in esophageal cancer image-guided radiotherapy Melanie Machiels* 1,
Orthogonal and Least-Squares Based Coordinate Transforms for Optical Alignment Verification in Radiosurgery Ernesto Gomez PhD, Yasha Karant PhD, Veysi.
M. D. Anderson Cancer Center Houston, TX
Chain Reactions Chain Reaction - the series of repeated fission reactions caused by the release of neutrons in each reaction.
AAPM Annual Meeting, Anaheim, California July 13, 2015
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
PET-utilized proton range verification using 13N signals
OPTICAL MONITORING OF PHOTOSENSITIZER DIFFUSION INTO TISSUE
Feasibility of using O-18 for PET proton range verification
Dosimetry of Alternative Techniques for Accelerated Partial Breast Irradiation Hanh Pham, B.S, CMD, Thanh Nguyen, BS, Christina Henson, MD, Salahuddin.
Figure 2 Nonmalignant tissue can be spared from radiation
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
Figure 3 Craniospinal irradiation proton therapy for medulloblastoma
Evaluation of Average CT to reduce the artifact in PET/CT
William Hartsell, M.D. Medical Director
Average Dose-Volume Ratio
Presentation transcript:

Proton range verification with PET: 68Zn, Cu and polycarbonate activation SNMMI Young Investigator Symposium, Vancouver, June 9, 2013 Cho J1, Ibbott G1, Gillin M1, Gonzalez-Lepera C2, and Mawlawi O3. 1 Department of Radiation Physics 2 Department of Nuclear Medicine 3 Department of Imaging Physics University of Texas MD Anderson Cancer Center, Houston, TX PET imaging for proton therapy verification. Please interrupt me anytime for questions.

Outline Background Purpose Measurements Future application Proton therapy Use of PET for proton range verification Current limitations Purpose Proton activated fiducial markers for range verification Measurements Activation comparison of 68Zn, Cu and polycarbonate Future application

X-ray therapy vs. Proton therapy high dose low dose low dose high dose Dose (%) Proton X-ray Depth (cm)

Proton range verification by imaging tissue activation Dose Proton Tissue activation PET Limitations No or weak PET signal at the end of proton range PET Activity washout Short half-lives → Requires in-beam or on-site PET (additional cost !) Parodi et al, NIH public access 2007

Purpose: 68Zn and 63Cu as implantable markers Overcome limitations by High PET signal at the end of proton range Activated marker No activity washout Not activated marker Relatively long half-lives → Off-site PET utilized (already available !)

68Zn and Cu(70% 63Cu) activation (no background) 30 min PET scan after 50 min delay 12.5 Gy

68Zn and Cu activation (with background) 30 min PET scan after 48 min delay 50 mm3 5 Gy Signal reduced

Limitation Point verification vs. Volume verification Invasive Fiducial migration Sensitivity (signal vs. fiducial volume) PET

Conclusion 68Zn / Cu foils were activated much stronger and at deeper depths than PC. 68Zn / Cu foils’ activation were stronger than background activation from balsa wood. 68Zn / Cu may be feasible as implantable fiducial markers for proton range verification.

Future application as a fiducial replacement Proton activated fiducial Non-activated fiducial

Thank you. Acknowledgement Reinhard Schulte at Loma Linda University Medical Center. Pablo Yepes at Rice University. Wen Hsi at ProCure Treatment Center. Francesco Stingo Bryan Steward Kevin Casey Kevin Vredevoogd Richard Amos Matthew Kerr at UT MD Anderson Cancer Center.

68Zn and Cu activation in meat phantom 126 min delay, 30 min PET scan 5 Gy

68Zn and Cu activation with depth 12.5 Gy 50 min delay, 150 min PET scan

Sensitivity of 68Zn and Cu for different volumes

X-ray therapy vs. Proton therapy Healthy tissue Tumor Critical organ

X-ray therapy vs. Proton therapy Healthy tissue Tumor Critical organ

X-ray therapy vs. Proton therapy

Proton therapy verification using PET Incident proton beam Nucleus in patient patient Parodi et al, NIH public access 2007